ViaLase announced the first patient was treated in a U.S. IDE clinical trial evaluating its femtosecond laser trabeculotomy ...
Eyes that switched from eye drops to SLT had a significant reduction in the average number of medications. Eyes with uncontrolled IOP benefited from SLT, but some still needed trabeculectomy.
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Average IOP reductions were 23.04% at 6 months and 25.74 ...
More than 70 million people worldwide suffer from glaucoma, a condition that causes a build-up of fluid and pressure inside the eye and can eventually lead to blindness. Treatment options have ...
More than 70 million people worldwide suffer from glaucoma, a condition that causes a build-up of fluid and pressure inside the eye and can eventually lead to blindness. Treatment options have ...
Stead added that while SLT is now the first treatment that is offered to patients, a range of topical medications in the form ...
Laser treatment has the potential to transform the management of glaucoma in Africa, and to prevent more people from going irreversibly blind, particularly in regions with high disease prevalence and ...
Laser treatment has the potential to transform the management of glaucoma in Africa, and to prevent more people from going irreversibly blind, particularly in regions with high disease prevalence and ...
Surgical Laser Technologies received FDA approval to market its Sinu-Clear surgical procedure and instruments, a laser treatment for nasal and sinus polyps. SLT already has clearances for ear, nose, ...
More than 70 million people worldwide suffer from glaucoma. Treatment options have traditionally included eye drops to reduce the fluid the eye produces or surgery to unclog the eye's drainage. But a ...
Laser treatment has the potential to transform the management of glaucoma in Africa, and to prevent more people from going irreversibly blind, particularly in regions with high disease prevalence and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback